Health care biotech companies by today's price change
How far the share price has moved since the previous close.
Scholar Rock Holding leads the 24 health care biotech companies ranked by today's price change, at +5.06%, ahead of CG Oncology (+1.24%) and Moderna (+0.89%). Figures as of 19 Nov 2026, 20:31 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Scholar Rock Holding+5.06%
- Median
- -1.04%
- Combined market value
- SAR 3.1T
- Countries
- 5
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Scholar Rock HoldingSRRK · Health Care | +5.06% | SAR 23.1B | SAR 189.16 | 5.06% up | 26% up | ||
| 2 | CG OncologyCGON · Health Care | +1.24% | SAR 27.1B | SAR 303.79 | 1.24% up | 97% up | ||
| 3 | ModernaMRNA · Health Care | +0.89% | SAR 301.3B | SAR 744.70 | 0.89% up | 780% up | ||
| 4 | Bio-TechneTECH · Health Care | -0.05% | SAR 42.8B | SAR 272.74 | 0.05% down | 24% up | ||
| 5 | Krystal BiotechKRYS · Health Care | -0.08% | SAR 35B | SAR 1,181.90 | 0.08% down | 54% up | ||
| 6 | argenxARGX · Health Care | -0.13% | SAR 221.7B | SAR 3,526.15 | 0.13% down | 2% up | ||
| 7 | QiagenQGEN · Health Care | -0.13% | SAR 38.3B | SAR 185.66 | 0.13% down | 9% up | ||
| 8 | Kodiak SciencesKOD · Health Care | -0.15% | SAR 24B | SAR 366.32 | 0.15% down | 399% up | ||
| 9 | Revolution MedicinesRVMD · Health Care | -0.16% | SAR 129.5B | SAR 598.55 | 0.16% down | 129% up | ||
| 10 | VaxcytePCVX · Health Care | -0.29% | SAR 34.6B | SAR 218.87 | 0.29% down | 23% up | ||
| 11 | Adaptive BiotechnologiesADPT · Health Care | -0.93% | SAR 17.1B | SAR 105.76 | 0.93% down | 74% up | ||
| 12 | Kymera TherapeuticsKYMR · Health Care | -0.94% | SAR 38.4B | SAR 450.08 | 0.94% down | 87% up | ||
| 13 | AmgenAMGN · Health Care | -1.13% | SAR 890.4B | SAR 1,646.16 | 1.13% down | 32% up | ||
| 14 | Gilead SciencesGILD · Health Care | -1.39% | SAR 775.3B | SAR 625.05 | 1.39% down | 35% up | ||
| 15 | RepligenRGEN · Health Care | -1.88% | SAR 40.6B | SAR 635.49 | 1.88% down | 12% up | ||
| 16 | BiogenBIIB · Health Care | -1.98% | SAR 136.6B | SAR 924.37 | 1.98% down | 49% up | ||
| 17 | ImmunovantIMVT · Health Care | -2.31% | SAR 25.2B | SAR 121.55 | 2.31% down | 46% up | ||
| 18 | BioNTechBNTX · Health Care | -2.62% | SAR 75.4B | SAR 304.13 | 2.62% down | 14% down | ||
| 19 | Halozyme TherapeuticsHALO · Health Care | -3.18% | SAR 39.7B | SAR 347.92 | 3.18% down | 39% up | ||
| 20 | Neurocrine BiosciencesNBIX · Health Care | -3.21% | SAR 59.8B | SAR 591.27 | 3.21% down | 17% up | ||
| 21 | ImmunityBioIBRX · Health Care | -3.36% | SAR 25.8B | SAR 24.29 | 3.36% down | 232% up | ||
| 22 | CRISPR TherapeuticsCRSP · Health Care | -3.88% | SAR 14.1B | SAR 144.90 | 3.88% down | 18% down | ||
| 23 | ExelixisEXEL · Health Care | -3.97% | SAR 60B | SAR 245.99 | 3.97% down | 63% up | ||
| 24 | Twist BioscienceTWST · Health Care | -4.25% | SAR 28.5B | SAR 417.88 | 4.25% down | 346% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which health care biotech companies rank first by today's price change?
Scholar Rock Holding (+5.06%), CG Oncology (+1.24%) and Moderna (+0.89%) are the top three of the 24 health care biotech companies ranked by today's price change as of 19 Nov 2026, 20:31 UTC.
How many health care biotech companies are in this ranking?
24 are ranked by today's price change.
What are these health care biotech companies worth together?
The 24 health care biotech companies ranked by today's price change have a combined market value of SAR 3.1T as of 19 Nov 2026, 20:31 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care biotech companies by today's price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.